Fibrogenic Pathways in Metabolic Dysfunction Associated Fatty Liver Disease (MAFLD)

The prevalence of nonalcoholic fatty liver disease (NAFLD), recently also re-defined as metabolic dysfunction associated fatty liver disease (MAFLD), is rapidly increasing, affecting ~25% of the world population. MALFD/NAFLD represents a spectrum of liver pathologies including the more benign hepati...

Descripción completa

Detalles Bibliográficos
Autores principales: Subramanian, Pallavi, Hampe, Jochen, Tacke, Frank, Chavakis, Triantafyllos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9266719/
https://www.ncbi.nlm.nih.gov/pubmed/35805998
http://dx.doi.org/10.3390/ijms23136996

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9266719/
https://www.ncbi.nlm.nih.gov/pubmed/35805998
http://dx.doi.org/10.3390/ijms23136996

Ejemplares similares